https://lysiniatx.com 2026-08-25 daily 1.0 https://lysiniatx.com/assets/images/image01.jpg https://lysiniatx.com/assets/images/gallery01/b4bb18fa.jpg CEO: Edward A Kesicki, PhD. Medicinal Chemist. Thirty-year drug discovery career in Biotech and Pharma. Retired from Eli Lilly. https://lysiniatx.com/assets/images/gallery01/706e2871.jpg Founder: Robert J. DeVita, PhD. Professor, Icahn School of Medicine. Medicinal Chemist. Thirty years experience in Pharma (Merck), Biotech, and Academia https://lysiniatx.com/assets/images/gallery01/897b997e.jpg Founder: Sander Houten, PhD. Professor, Icahn School of Medicine. Medical biologist with over twenty-five years researching inborn errors of metabolism. Leading expert in GA-1, Glutaric Aciduria Type 1. https://lysiniatx.com/assets/images/gallery01/2d31d266.jpg Founder: Michael Lazarus, PhD. Assoc. Professor, Ichan School of Medicine. Protein biochemist and structural biologist with over fifteen years of experience in academia. First crystal structure of our target protein. https://lysiniatx.com/assets/images/gallery02/152607bd.jpg Untitled